Product NDC: | 0009-0225 |
Proprietary Name: | Cleocin Hydrochloride |
Non Proprietary Name: | CLINDAMYCIN HYDROCHLORIDE |
Active Ingredient(s): | 150 mg/1 & nbsp; CLINDAMYCIN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0225 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050162 |
Marketing Category: | NDA |
Start Marketing Date: | 19700522 |
Package NDC: | 0009-0225-02 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0009-0225-02) |
NDC Code | 0009-0225-02 |
Proprietary Name | Cleocin Hydrochloride |
Package Description | 100 CAPSULE in 1 BOTTLE (0009-0225-02) |
Product NDC | 0009-0225 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLINDAMYCIN HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19700522 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |